Abstract
Researchers with the international, multicenter Study of Biologic and Immunomodulator Naive Patients in Crohn's Disease (SONIC) study found that nearly 57% of Crohn's patients who received combination therapy with infliximab and azathioprine achieved steroid-free remission after 26 weeks. The study appears in the April 15, 2010, issue of The New England Journal of Medicine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
